This HTML5 document contains 195 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/
n10http://dx.doi.org/10.1128/

Statements

Subject Item
wd:Q33558937
rdf:type
wikibase:Item
schema:description
artykuł naukowy artikulong pang-agham 2009年の論文 научная статья 2009年论文 articol științific mokslinis straipsnis наукова стаття, опублікована в листопаді 2009 vedecký článok wissenschaftlicher Artikel vitenskapelig artikkel 2009년 논문 2009年論文 ২০০৯-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ bilimsel makale 2009 nî lūn-bûn мақолаи илмӣ مقالهٔ علمی სამეცნიერო სტატია 2009年论文 2009年論文 artigo científico scientific article 2009年论文 2009年論文 scienca artikolo teaduslik artikkel מאמר מדעי article científic artikull shkencor 2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած научна статия 2009年论文 artigo científico (publicado na 2009) naučni članak 2009年论文 επιστημονικό άρθρο tieteellinen artikkeli articolo scientifico 2009年論文 2009 թվականի նոյեմբերին հրատարակված գիտական հոդված tudományos cikk บทความทางวิทยาศาสตร์ article scientific vědecký článek artigo científico (publicado na 2009) 2009年论文 2009年論文 wetenschappelijk artikel научни чланак artículo científico publicado en 2009 سائنسی مضمون научни чланак мақолаи илмӣ artículu científicu espublizáu en 2009 videnskabelig artikel (udgivet 2009) vitskapeleg artikkel bài báo khoa học مقالة علمية vetenskaplig artikel article scientifique (publié 2009)
p:P577
wds:Q33558937-AE27D0A6-C992-47B3-9825-21C592F10E21
wdt:P577
2009-11-09T00:00:00Z
p:P407
wds:Q33558937-0D81625D-A4D7-4F80-816A-B283EDE38151
wdt:P407
wd:Q1860
p:P2860
wds:Q33558937-8E03E488-1D52-4ED3-925C-D74275F339BF wds:Q33558937-8FA5D8CE-6BCE-492A-8FD3-C708E2FE238D wds:Q33558937-A9AA8BD8-D766-4FB1-9AB5-D9696890A05C wds:Q33558937-B04A47A8-4AD8-4DE9-B115-79D10AFC93BA wds:Q33558937-751FC3B5-82D9-4F5C-809F-DE800EB63904 wds:Q33558937-78D0979C-D55A-4A0E-ACD1-84216FBD35D2 wds:Q33558937-7CF146F7-A274-4989-AB3D-0699702B1424 wds:Q33558937-8A563852-3B5D-435D-BEEA-5FEE720C8CE3 wds:Q33558937-D82C1264-67C3-432E-A490-A5AA49EB8C2E wds:Q33558937-E75E7895-8AA4-4EB2-8A32-F1B88AE9DE33 wds:Q33558937-B7D82BF2-7E06-43C3-AC37-6F63C3F4C332 wds:Q33558937-C056F2BE-D102-422F-9972-4DB5D537913D wds:Q33558937-CE6BB204-AAB0-4217-A150-9A68E3EDC87D wds:Q33558937-F035C403-A5A1-4E41-BB74-4C1406D21600 wds:Q33558937-131EF542-2D2F-4049-A400-5E98609E6771 wds:Q33558937-24C5D942-95C0-42BB-9F81-ACC4CE1DC879 wds:Q33558937-2535BA3C-1E49-40CF-A2B3-91AC67ED410A wds:Q33558937-61D8486D-873B-4D8C-84BA-75E2598DE64A wds:Q33558937-62C31B10-6381-4319-9C81-9108A2B8CB4F wds:Q33558937-6BE549AB-7C99-4C06-89E9-7DB9C9158B83 wds:Q33558937-2BE8D6A4-11B3-4C12-98F6-2B9A8582446F wds:Q33558937-305BBE7C-5BD4-4904-8153-A116A8328173 wds:Q33558937-312785ED-F5BE-4381-A714-AE7C2768FD3B
wdt:P2860
wd:Q44465176 wd:Q46160845 wd:Q37357605 wd:Q39160277 wd:Q46968863 wd:Q39268433 wd:Q37423276 wd:Q36870850 wd:Q57480046 wd:Q40425001 wd:Q45165529 wd:Q36993465 wd:Q46662766 wd:Q33851627 wd:Q27638329 wd:Q48472661 wd:Q51910874 wd:Q51910877 wd:Q44669992 wd:Q56837848 wd:Q46463863 wd:Q42033549 wd:Q27628304
p:P2093
wds:Q33558937-F6E5A413-F228-40D3-BC40-E2AA3130B996 wds:Q33558937-3BC4A3D6-4A80-4DFE-ADE9-9989EB0B537D wds:Q33558937-15849025-1931-454C-B306-03DE1E71023B wds:Q33558937-03D91EF8-35E1-479F-9625-2FCD00176A64
wdt:P2093
Laurence Morand-Joubert Henia Saoudin Georges Dos Santos Vincent Calvez
rdfs:label
Factors associated with virological response to etravirine in nonnucleoside reverse transcriptase inhibitor-experienced HIV-1-infected patients Factors associated with virological response to etravirine in nonnucleoside reverse transcriptase inhibitor-experienced HIV-1-infected patients Factors associated with virological response to etravirine in nonnucleoside reverse transcriptase inhibitor-experienced HIV-1-infected patients.
skos:prefLabel
Factors associated with virological response to etravirine in nonnucleoside reverse transcriptase inhibitor-experienced HIV-1-infected patients Factors associated with virological response to etravirine in nonnucleoside reverse transcriptase inhibitor-experienced HIV-1-infected patients Factors associated with virological response to etravirine in nonnucleoside reverse transcriptase inhibitor-experienced HIV-1-infected patients.
schema:name
Factors associated with virological response to etravirine in nonnucleoside reverse transcriptase inhibitor-experienced HIV-1-infected patients Factors associated with virological response to etravirine in nonnucleoside reverse transcriptase inhibitor-experienced HIV-1-infected patients. Factors associated with virological response to etravirine in nonnucleoside reverse transcriptase inhibitor-experienced HIV-1-infected patients
p:P50
wds:Q33558937-466F7581-1689-4149-A488-38CF5F6A81DB wds:Q33558937-4A410B0A-5F67-4D26-AF34-A3600D46745C wds:Q33558937-29B0C731-F67B-4B8A-84E6-24424CC1B103 wds:Q33558937-2B844B9D-4C10-4421-9CDA-4F054F141CAA wds:Q33558937-68645B75-2112-4835-B3CD-69FDBCAC8862 wds:Q33558937-74684835-0F71-4E22-A56C-D8A454FBC7DC wds:Q33558937-4C79E3F4-F26B-4B0A-B14A-3D92ABBCE603 wds:Q33558937-63D2D1C1-8F96-43D1-A75E-9C285822A979 wds:Q33558937-0E9AB5A0-AB63-44EE-B4DC-3383CD9BA2A4 wds:Q33558937-CBF54AF4-2534-49E7-8DF5-4E81AEB0A58B wds:Q33558937-D2143D18-33E6-4F3C-AA65-B851EE38F6C9 wds:Q33558937-B59AC538-3FFD-4B47-8F68-11E9E5D128FA wds:Q33558937-C3127697-EF18-40A6-AEB6-068E8064ACBE wds:Q33558937-E47D7FF6-884D-4C64-AF41-D1F43534653E wds:Q33558937-D26EFB12-072F-40A2-8590-143F2D121597 wds:Q33558937-D5A82752-CC97-4257-8835-C0B9988FED1D wds:Q33558937-8646AEB7-FD4C-4E77-94EE-FDDC60AFA38F wds:Q33558937-88D1C8F3-FF2E-4249-B9C0-9CDA7D18D4C0 wds:Q33558937-920E6A59-48A9-4186-B80E-509483BB3C3D wds:Q33558937-8D443B7E-8FF9-4804-85FF-A907E5C560F9 wds:Q33558937-FDEFD157-BB81-4861-9E19-64C443445E38
wdt:P50
wd:Q111077180 wd:Q63142552 wd:Q63142566 wd:Q114401788 wd:Q114401786 wd:Q114401787 wd:Q114371678 wd:Q114401783 wd:Q114401784 wd:Q114401781 wd:Q114401782 wd:Q56843083 wd:Q91011041 wd:Q88255515 wd:Q87030123 wd:Q41564210 wd:Q41564214 wd:Q47006545 wd:Q47006659 wd:Q37367397 wd:Q28595173
p:P1476
wds:Q33558937-80F75390-F7C2-409D-BD4A-9703A248CCD3
wdt:P1476
Factors associated with virological response to etravirine in nonnucleoside reverse transcriptase inhibitor-experienced HIV-1-infected patients
p:P304
wds:Q33558937-8198FCCB-D2CC-499A-872A-A3AA9760C14C
wdt:P304
72-77
p:P31
wds:Q33558937-14828F2D-D014-4A12-8866-61B8B85AEF89
wdt:P31
wd:Q13442814
p:P921
wds:Q33558937-DCD04801-9E1A-4D7B-8DE6-A2E44EE8D3B8
wdt:P921
wd:Q7215
p:P698
wds:Q33558937-248AF459-DD0E-422C-BA41-7D6183167A2E
wdtn:P698
n12:19901096
wdt:P698
19901096
p:P1433
wds:Q33558937-8D6E3636-CC76-4B72-AEDD-D8BB7391AC28
wdt:P1433
wd:Q578004
p:P433
wds:Q33558937-02464402-0AAB-4EE4-8F70-3D4CFE8E3769
p:P478
wds:Q33558937-703AB5A3-A944-4520-8C81-9FF5A1721ED8
wdt:P433
1
wdt:P478
54
p:P356
wds:Q33558937-CB4CF3F0-9412-4AC6-BC78-15FEB38BDC36
wdtn:P356
n10:AAC.01051-09
wdt:P356
10.1128/AAC.01051-09
p:P5875
wds:Q33558937-ED0C21DF-C46F-4551-AFBA-D4822A705637
wdt:P5875
38077934
p:P932
wds:Q33558937-EDEEC37F-6D67-4CC8-B93E-B895A264D06B
wdt:P932
2798499